Nuveen Churchill Direct Lending Corp.
NCDL NYSE Financials FY2021–FY2025
Last close · Oct 23, 2026
$10.55
0.5%What Nuveen Churchill Direct Lending Corp. does
No business description yet.
- Legal name
- Nuveen Churchill Direct Lending Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Accession · CIK
- 0001737924-26-000014
0001737924
Revenue and margins
Nuveen Churchill Direct Lending Corp. had — of revenue in fiscal 2025.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew 4.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nuveen Churchill Direct Lending Corp. returned $168M to shareholders in fiscal 2025. The diluted share count fell 7.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nuveen Churchill Direct Lending Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $35.2M | $39.3M | $67.4M | $43.3M | $62.5M |
| Debt incl. finance leases | — | $705M | $952M | $1.1B | $1.1B |
| Debt / equity | — | 1.3x | 1.3x | 1.1x | 1.3x |
| Total assets | — | $1.3B | $1.7B | $2.1B | $2.1B |
| Total liabilities | — | $729M | $983M | $1.2B | $1.2B |
| Shareholders' equity | $374M | $525M | $748M | $970M | $875M |
| Net debt (− = net cash) | — | $666M | $884M | $1.1B | $1.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✕ | ✕ | ✕ | ✓ |
| Return on assets rose | — | — | ✓ | ✓ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✕ | ✕ | ✓ |
| Debt fell relative to assets | — | — | ✓ | ✓ | ✕ |
| Current ratio rose | — | — | — | — | — |
| Share count didn't rise | — | ✓ | ✕ | ✕ | ✓ |
| Gross margin rose | — | — | — | — | — |
| Revenue rose relative to assets | — | — | — | — | — |
| F-score | — / 3 | — / 4 | — / 6 | — / 6 | — / 6 |
| Accruals ratio | — | 35.5% | 29.8% | 21.3% | −6.1% |
| Altman Z'' | — | — | — | — | — |
5 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Income tax | — | — | — | — | $0.8M |
| Net income | $27.3M | $17.3M | $75.9M | $116M | $65.6M |
| Diluted EPS | $1.58 | $1.95 | $2.52 | $2.26 | $1.86 |
| Diluted shares | 12.85B | 0.02B | 0.03B | 0.05B | 0.05B |
| Cash flow | |||||
| Cash from operations | −$389M | −$428M | −$370M | −$297M | $194M |
| Share buybacks | — | $0.0M | $0.0M | $33.5M | $65.7M |
| Dividends paid | $14.7M | $34.7M | $63.2M | $95.2M | $102M |
| Dividends and buybacks | $14.7M | $34.7M | $63.2M | $129M | $168M |
| Balance sheet | |||||
| Cash and short-term investments | $35.2M | $39.3M | $67.4M | $43.3M | $62.5M |
| Total debt | — | $705M | $952M | $1.1B | $1.1B |
| Total assets | — | $1.3B | $1.7B | $2.1B | $2.1B |
| Total liabilities | — | $729M | $983M | $1.2B | $1.2B |
| Shareholders' equity | $374M | $525M | $748M | $970M | $875M |
| Returns | |||||
| Return on equity | 7.3% | 3.8% | 11.9% | 13.5% | 7.1% |
| Return on assets | — | 1.4% | 5.1% | 6.0% | 3.1% |
| Return on tangible equity | 7.3% | 3.3% | 10.2% | 12.0% | 7.5% |
| Growth | |||||
| Net income growth | — | −36.6% | 339.3% | 53.2% | −43.6% |
| EPS growth | — | 23.4% | 29.2% | −10.3% | −17.7% |
| Share count change | — | −99.8% | 43.4% | 62.1% | −7.1% |
| Financial health | |||||
| Debt / equity | — | 1.3x | 1.3x | 1.1x | 1.3x |
| Quality scores | |||||
| Accruals ratio | — | 35.5% | 29.8% | 21.3% | −6.1% |
Source: SEC EDGAR XBRL filings (CIK 0001737924). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
